Nifurtimox and benznidazole represent the only treatments options available targeting Chagas disease, the most important parasitic infection in the Americas. However, use of these is problematic as they are toxic and ineffective against the more severe stages of the disease. In this work, we used a multidisciplinary approach to characterise the fumarases from Trypanosoma cruzi, the causative agent of Chagas Disease. We showed this trypanosome expresses cytosolic and mitochondrial fumarases that via an iron-sulfur cluster mediate the reversible conversion of fumarate to S-malate.
Introduction
Throughout Latin America approximately 8 million people suffer from Chagas disease, a neglected tropical infection caused by the flagellated protozoan parasite Trypanosoma cruzi (World Health Organization, 2013 ). This disease is characterised by a series of life-threatening mega syndromes that promote damage to the heart, intestines and central nervous system, severely affecting the quality of life of infected patients [1] .
The normal route of transmission of this zoonotic infection is via the hematophagous behaviour of insects belonging to the Reduviidae family, in which part of T. cruzi's life cycle occurs, to humans, where the cycle is completed [2] . However, as a result of alternative modes of transmission such as through blood transfusions, organ transplantation, congenital and ingestion of contaminated food [3] , and population migration, Chagas disease has started to emerge as a public health problem at nonendemic sites such as the USA and Europe [4] .
Benznidazole and nifurtimox currently represent the only treatment options available against Chagas disease but their use is controversial. They are highly toxic and not effective in curing the infection during the lethal disease staging while some strains are refractory to treatment. In addition, the drug regimens are prolonged with a course of treatment requiring multiple daily doses taken over a 1 to 4 month period. Often, the recommended schedules are not completed, usually because of their side effects, resulting in considerable scope for the development of resistance. There is a considerable need for novel therapeutic strategies targeting Chagas disease and exploring the biochemistry of T.
cruzi is seen as an important strategy to identify and validate new drug targets for the development of innovative treatments [5] .
Fumarases (EC 4.2.1.2), also known as fumarate hydratases, are ubiquitous enzymes that catalyse the reversible conversion of fumarate to L-malate [6] . Based on sequence, structure, biochemical properties and co-factors, they can be divided into three distinct types [7] . Class I fumarases primarily expressed by bacteria and some protozoa, are homodimeric iron-sulfur (4Fe-4S) containing enzymes of approximately 120 kDa in size, and are readily inactivated by superoxide anions, heat or radiation.
In contrast, class II fumarases are homotetrameric, iron independent proteins of approximately 200 kDa in size that are expressed by bacteria and numerous eukaryotes including higher plants, fungi and mammals [8] . Higher eukaryotic cells express one class II enzyme that is dual localized by reverse translocation after undergoing proteolytic processing to generate different echoforms [9] [10] [11] . One of these forms is localized to the mitochondrion where it participates in the Kreb's cycle while the second, located in the cytosol, plays a role in amino acid and fumarate metabolism. Intriguingly, the cytosolic variant is postulated to participate in the cellular response to DNA double strand breaks with this enzyme undergoing transport into the nucleus [12] . A third fumarase class has been identified from prokaryotes. This enzyme is composed of a heterodimer with an alpha and a beta subunit resembling the N-terminal and C-terminal parts of class I fumarase, respectively [13, 14] .
Analysis of the trypanosomal databases has shown that trypanosomes have the potential to express two class I fumarases, enzymes that are completely distinct from the class II counterparts found in humans. This, coupled with the observation that the total fumarase activity in an insect-stage Trypanosoma brucei cell is essential for parasite viability [15] , prompted us to evaluate whether these enzymes constitute anti-chagasic drug targets. Here, we show that the total fumarase activity is important, if not essential, for T. cruzi viability and that both T. cruzi enzymes catalyse the reversible conversion of fumarate to L-malate with this activity being readily inhibited by the sulfur-containing malate derivative, thiomalate. Our results suggest that fumarase could be exploited as a potential drug target in T. cruzi and thus selective inhibiton of fumarase may constitute a new strategy against Chagas disease. The mean number of parasites found in all host cells (mean abundance) was calculated using the quantitative software (QPweb 1.0) with 95% confidence interval by the bias-corrected and accelerated (BCa) bootstrap method with 2000 bootstrap replications.
Materials and Methods

Cell culturing
Protein purification
The vectors used to express various fumarases in E. coli were generated as follows: full length Tcfhc added to the growth medium. All subsequent purification steps were performed under anaerobic conditions. The cells were resuspended in buffer A (50 mM NaH2PO4, pH 8.5, 300 mM NaCl, 10 mM imidazole) containing 1 mM phenylmethylsulfonyl fluoride then disrupted by sonication using 10 x 30 s pulses on ice. The clarified lysate was passed through a Ni-NTA resin (Qiagen) equilibrated with buffer A. The resin was washed with the same buffer containing 25 mM imidazole and then reequilibrated with buffer A. The histidine tagged protease ULP1 (500 µg) was added to the resin, the column incubated overnight at 8 °C. Tag-free enzymes were then eluted off the column with buffer A. Enzymes were concentrated and dialyzed against the storage buffer (50 mM Tris pH 8.5, and 150 mM NaCl) using an ultra-filter unit with 30 kDa cutoff (Amicon-Millipore).
Size exclusion chromatography of TcFHc was carried out using an isocratic run (50 mM Tris pH 8.5, 600 mM NaCl, 10 mM imidazole and 1 mM DTT) in a Superdex 200 10/300 (GE Life Sciences).
The oligomeric state was estimated using molecular weight markers according to the column manufacturer's instructions.
3 Enzyme kinetics
TcFHc and TcFHm activities were monitored under anaerobic conditions by following the change in absorbance at 250 nm due to consumption or formation of fumarate (ε250nm=1.45 mM -1 cm -1 [18] ).
A reaction mixture containing 50 mM Tris pH 8. 
Inhibition studies
The effect of thiomalate (Sigma) on the initial reaction rates of TcFHc and HsFH was assessed.
TcFHc activity in 50 mM Tris pH 8.5, 150 mM NaCl buffer was followed in varying amounts of Lmalate (8, 4 Inhibition of TcFHc using different compounds possessing free thiol groups was also tested. In these assays activity was evaluated in buffers containing 50 mM Tris pH 8.5, 150 mM NaCl and 8 mM Lmalate in presence of different concentrations (50 mM, 10 mM, 2 mM, 400 µM, 80 µM, 16 µM, 3.2 µM, 640 nM and 128 nM) of β-mercaptoethanol (BME), cysteine (Cys), reduced glutathione (GSH), dithiotreitol (DTT) and sodium meso-2,3-dimercaptosuccinate (DMSA).
Electron paramagnetic resonance
EPR measurements were performed to assess the presence of an iron-sulfur cluster in TcFHc and TcFHm. A Bruker Elexsys E580 spectrometer operating at X band (9.5 GHz) equipped with a rectangular cavity was utilized. The optimal temperature for the experiments, around that of liquid helium (4-10 K), was reached using an Oxford ITC 503 cryostat. The parameters were optimized to avoid signal saturation and distortion with the final values: 10 mW microwave potency, 0.2 mT magnetic field modulation and 100 kHz magnetic field modulation frequency. Samples contained 87
µM of protein in a total volume of 50 µL.
Localization studies
To 
Gene disruption
The constructs used to disrupt the T. cruzi fumarase genes were generated as follows: Primers were designed to amplify 450 or 471 bp fragments from the 5' and 3' region of the Tcfhc gene, respectively.
These were cloned sequentially either side of a puromycin-(pac) or blasticidin-(bla) containing resistance cassette. Similarly, primers to designed to amplify 490 and 484 bp DNA fragments from the 5' and 3' region of the Tcfhm gene, respectively. These were cloned sequentially either side of a 
Results
Trypanosoma cruzi enzymes display type I fumarase characteristics
Two ORFs in the T. cruzi genome database [22] were identified as having potential to encode for 62 kDa proteins related to fumarase enzymes. One 1698 bp sequence (TcCLB.507257.60) located on chromosomes 36 was designated as Tcfhc and the second 1668 bp ORF (TcCLB.507669.10) found on chromosomes 26 was designated as Tcfhm. The deduced amino acid sequence of the two T. cruzi fumarases share 61% identical residues to each other with most of the differences found in their amino termini, and shared 75 to 82% identical residues to their T. brucei and Leishmanial orthologues, respectively. When TcFHc and TcFHm were compared to fumarases from other organisms they exhibited significant identity (~60%) to the class I enzymes from unicellular eukarytotes and bacteria and no similarity to the class II fumarases present in higher eukarytotes such as humans.
To facilitate their biochemical characterisation TcFHc and TcFHm were expressed as 6x(His)-SUMO amino termini tagged proteins in E. coli, affinity purified on a Ni 2+ column and eluted off the matrix following cleavage with the ULP1 protease, releasing the untagged fumarase ( Figure 1A ). To determine its oligomeric state, purified TcFHc was subjected to size exclusion chromatography, eluting off the column as a size peak of ~147 kDa ( Figure 1B ). This is close to the expected size of a dimeric protein (124 kDa), in agreement to the quaternary structure reported for class 1 fumarases [7] . To investigate co-factor binding the EPR profiles of TcFHc and TcFHm were assessed ( Figure   1C and D 
Trypanosoma cruzi expresses two functional fumarases
In other organisms fumarases catalyse the reversible hydration/dehydration of fumarate/malate. To determine whether the trypanosomal enzymes could perform these reactions, the ability of purified TcFHc and TcFHm to convert fumarate to malate (hydration) and malate to fumarate (dehydration) was monitored by following the change in absorbance at 250 nm. Initial assays conducted under anaerobic conditions and using fix amount of substrate (1 mM) revealed that both parasite enzymes could readily catalyse the above reactions with an optimal pH of 8.0 to 9.0. To study the interaction of TcFHc and TcFHm with the two substrates further, assays were then performed in the presence of a fixed amount of parasite enzyme (10 µg) using different concentrations of fumarate/malate substrates ( Table 1 ). This revealed that TcFHc catalysed the hydration and dehydration reactions following the Hill model with a Hill coefficient (h) of 1.4, with its catalytic efficiency (kcat/k0.5 h ), calculated as suggested in [28] , towards the hydration of fumarate: this reaction was six-fold greater than the dehydration of malate. In contrast, TcFHm follows the simpler Michaelis-Menten mechanism (h = 1) for both reaction directions, displaying a four-fold higher catalytic efficiency for malate formation. This indicates that in vitro both TcFHc and TcFHm have a preference for the hydration reaction (i.e. fumarate consumption).
Localization of the T. cruzi fumarases
When analysed using PSORTII, TcFHm was predicted to contain an amino terminal sequence with potential to target the enzyme to the parasite's single mitochondrion. To confirm this, versions of TcFHm tagged at its carboxyl termini with a 10-amino acid epitope from the human c-myc protein (protein designated TcFHm-9e10) or with GFP (designated as TcFHm-GFP) were expressed in T.
cruzi epimastigotes. Using parasites expressing TcFHm-9e10, the distribution of the recombinant protein was assessed following digitonin permeabilization (Figure 2A ). This demonstrated that only soluble fractions obtained using the high concentrations of non-ionic detergent required for mitochondrial permeabilization were positive for tagged TcFHm. This subcellular location was confirmed using T. cruzi expressing TcFHm-GFP where the fluorescence signal was restricted to a lattice-like structure found throughout the cell, a pattern typical for trypanosomal proteins localized to the large single mitochondrion ( Figure 2B ). To confirm this, cells were co-stained with the mitochondrial dye, MitoTracker. When the images were superimposed, the pattern of colocalization indicated that TcFHm-GFP was located in the same compartment as MitoTracker. When the fluorescence studies were extended to investigate TcFHc localization, a GFP signal throughout the whole cell was observed indicating this fumarase has a cytosolic localization ( Figure 2C ).
Functional studies on T. cruzi fumarases
To investigate the importance of the fumarase repertoire to T. cruzi a reverse genetic approach was used. DNA fragments corresponding to the 5′ and 3' regions of Tcfhc were cloned either side of a cassette containing blasticidin or puromycin resistance markers. These were then linearized and transfected in T. cruzi epimastigotes to construct heterozyote (Tcfhc +/ ) and null mutant (TcfhcΔ) parasite lines. Southern hybridisation was used to confirm that each integration event had occurred and demonstrated that both copies of the full length Tcfhc gene could readily be deleted from the parasite genome ( Figure 3A and C). As lack of TcFHc had no effect on trypanosome growth and had no effect on the trypanosomes ability to infect and grow within mammalian cells ( Figure 3F ), by inference the cytosolic fumarase activity is non-essential for parasite growth under normal culture conditions. A similar strategy to interrupt both copies of the Tcfhm gene in the T. cruzi genome was employed resulting in construction of a Tcfhm +/-heterozygote and TcfhmΔ null mutants ( Figure 3B and D). By inference, TcFHm activity is non-essential for epimastigote growth under normal culture conditions. Intriguingly, when the growth of insect form epimastigote trypanosomes lacking TcFHm was followed, the parasites failed to grow in the initial 48-h period exhibiting a pronounced lag phase ( Figure 3E ). Additionally, when mammalian cells were infected with T. cruzi TcfhmΔ mutants and the parasites cultured as intracellular amastigotes, the trypanosome abundance load per host cell was ~3-fold lower than wild type ( Figure 3F ). This indicates that trypanosomes lacking TcFHm are less infective than parental parasites or that amastigote growth of the null line inside tissue cultured mammalian cell is somehow compromised.
To evaluate whether the combined fumarase activity is essential for parasite viability, attempts to interrupt both genes within a single cell to generate a TcfhcΔ TcfhmΔ double null mutant were initiated; in these experiments the Tcfhm puromycin-based integration constructs was modified such 
Developing a fumarase inhibitor
The gene disruption experiments suggest that the total fumarase activity may be essential for parasite viability. Encouraged by these observations, we became interested in evaluating this enzyme repertoire as a potential drug target and investigating whether inhibitors specifically targeting class I fumarases could be developed.
The mechanism of substrate binding to the iron-sulfur cluster was previously proposed by Flint [23] and suggests that both the hydroxyl group of the substrate malate and one oxygen of the closest carboxylate are responsible for chelating the labile iron of the 4Fe-4S cluster and allowing the reaction to occur ( Figure 4A ). According to the hard soft (Lewis) acid base theory [29] , the iron atoms of the cluster act as soft acids known to coordinate to thiol groups which are soft bases. Therefore, the chemistry of iron-sulfur clusters suggested to us that the replacement of a hydroxyl group (hard base)
of L-malate with a thiol, as observed in the thiomalate molecule ( Figure 4B ), could potentialize the binding with the active site iron-sulfur cluster and block the enzyme activity.
To test this hypothesis, parasite fumarase (10 µg) activity was measured in the presence of different for catalysis that only involves residues and no metal ( Figure 5A ), we expected thiomalate to be selective towards class I fumarases. In fact, thiomalate did not affect the activity of purified class II human fumarase ( Figure 5B ).
When the inhibition studies were extended to investigate other thiol-based compounds, most (BME, Cys, GSH, DTT) had no significant effect on TcFHc activity even at high concentrations (>10 mM), with only DMSA having an inhibitory effect at concentrations below 2 mM ( Figure 4E ).
Discussion
Fumarases represent a class of metabolic enzymes expressed by many prokaryotic and eukaryotic cells where they play key roles in pathways as diverse as the TCA cycle, amino acid metabolism and DNA repair [12] . Their importance in humans is manifest when the encoded activity becomes compromised such that reduction in fumarase levels can lead to a series of neonatal and infantile neurological conditions as well as in promoting certain cancers [30, 31] . Here, we demonstrate that over the substrate concentration range tested (Table 1) , TcFHc employed a catalytic mechanism with positive cooperativity, in agreement with its dimeric quaternary structure [33] . Since this profile was observed for both fumarate and malate, the interference of an optically impure substrate can be ruled out considering that fumarate is not a chiral molecule.
The localization of TcFHc to the cytosol and TcFHm to the mitochondrion as shown experimentally is in agreement with in silico predictions using Mitoprot [34] and experimental reports for the T. brucei and L. major homologues [15, 35] . However, computation analysis also indicates that TcFHc and TcFHm may also be present in glycosomes: glycosomes are modified peroxisomes within which several enzymes of the glycolytic pathway are compartmentalized. For TcFHc this additional localization, if ever exist, could be due to the presence of the -SKLL sequence at its carboxyl terminus, a region that resembles a classical peroxisomal targeting signal 1 (PTS1) (-SKL) tripeptide motif. What actually constitutes a PTS1 in glycosomes appears to be less stringent than for peroxisomes [36] [37] [38] [39] . Although structural studies involving T. brucei PEX5, the receptor that initiates protein translocation into the glycosome, in complex with modified PTS1 sequences has revealed that the extra leucine added onto the SKL-like tripeptide would occupy an unfavorable highly polar cavity which is actually filled by a 1,2-ethanediol molecule what would probably hinder the proteintransporter interaction [40] . As TcFHc contains this tetrapeptide arrangement at its carboxyl terminal it may not be recognized by the glycosomal transport machinery. In the case of TcFHm its amino terminal contains a mitochondrial signal peptide (MLRRSAA-) closely followed by an internal peroxisomal targeting signal 2 (PTS2) (-KYVPLIPHV-), an arrangement also noted for the L. major and T. brucei orthologs [41] . Using a combination of approaches we clearly show that carboxy terminal tagged versions of this fumarase are only present in the parasite's single mitochondrion and at no other sites within the cell.
The endogenous function of each individual T. cruzi fumarase is non-essential to T. cruzi: both copies of Tcfhc or Tcfhm could be readily deleted from the genome of epimastigote parasites. For trypanosomes lacking the cytosolic fumarase no obvious phenotype was observed with the recombinant parasites growing as insect form epimastigotes, invading mammalian cells as trypomastigotes or proliferating as intracellular amastigotes at levels equivalent to controls ( Figure   3F ). In contrast, deletion of both Tcfhm gene copies from the T. cruzi genome hampered the parasites ability to proliferate in its epimastigote and amastigote forms. As TcFHm most likely participates in the Kreb's cycle lack of its activity may alter the flux of metabolites within this pathway having a knock on effect in other biological systems such as in energy production and amino acid biosynthesis.
Because the mitochondrial enzyme is not essential for parasite growth it is implicit that its activity can be complemented possibly indicating that T. cruzi may have the ability to shuttle malate and fumarate between cellular compartments [22] (this may also explain why the cytosolic fumarase is non-essential) or that the TcFHm deficient cells are able to undergo some type of biochemical adaptation and metabolic reprogramming, analogous to leiomyomatosis renal carcinoma cells that are null for fumarase [42] .
The importance of the total fumarase activity to T. cruzi became evident when attempts were made to generate parasites lacking both genes. Here, three out of four fumarase gene alleles could readily be disrupted in epimastigote form trypanosomes with failure to interrupt the final gene strongly suggesting that the total fumarase activity is essential for parasite viability. Addition of malate or fumarate to the medium, a technique used to rescue for the fumarase knockdown phenotype in T.
brucei [15] , failed to generate the desired TcfhcΔ TcfhmΔ lines. The inability to complement for fumarase activity deficiency through supplementation of the medium with exogenous dicarboxylate indicates that T. cruzi epimastigotes may lack fumarate and malate transporters that facilitate their uptake into the cell.
Based on their biochemical features and apparent essential activity the T. cruzi fumarase repertoire possess many hallmarks required in a druggable target. To further assess whether these enzymes fulfil other criterion required for chemotherapeutic development, an assay for specific class I fumarases inhibitors was undertaken with thiomalate, a chemical rationally selected based on its similarity to the malate/fumarate substrates and low toxicity to humans [43] . Assays revealed that this structure could readily inhibit the trypanosomal fumarase activity without significantly affecting the human enzyme via a mechanism postulated to involve thiomalate selectively binding to the iron-sulfur cluster, a co-factor absent from HsFH [44] ( Figure 4A ). Thiomalate therefore represents a novel chemical lead that because of its low lipophilicity will require derivatization in order to develop more bioavailable variants that can be used against intracellular pathogens such as T. cruzi.
Our work has demonstrated that the T. cruzi fumarase complement should be investigated as a potential druggable anti-chagasic target and has resulted in the identification of a lead structure in the form of thiomalate. As several other medically important protozoan parasites including Plasmodium falciparum, Cryptosporidium and Leishmania also express class I fumarases then the work reported here may facilitate the development of novel strategies towards the development of new treatments for a range of globally important pathogens.
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